Posted Nov. 1, 2013 at 3:57 p.m.

Premium Lock GSK in line for $30M milestone payment after COPD drug launch

Published: 2013-11-01 15:57:21
Updated: 2013-11-01 15:57:21

Lung disease Lung disease

While GlaxoSmithKline gets a $30 million milestone for commercializing Breo Ellipta, drug partner Theravance stands to gain royalties on sales of the COPD drug. Read more about the drug....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders